CMU LICENSE AGREEMENT
Sudoc concludes an all-fields license agreement with Carnegie Mellon University for IP related to TAML catalysts
Innovative start-up offers game-changing products with significant environmental benefits
Sudoc, a new innovative chemical company committed to environmental sustainability, has completed an all-fields license agreement with Carnegie Mellon University (“CMU”) for IP related to a revolutionary invention—TAML catalysts. These catalysts solutions can replace and eliminate toxic chemicals in the environment which has significant implications for the sustainability of the planet.
The head of CMU’s Institute for Green Science, Dr. Terry Collins, has for over three decades led the work on developing TAML catalysts. Together with his teams, Dr. Collins has made a series of breakthroughs that have resulted in a family of catalysts that have the remarkable oxidation capabilities, while disappearing from our environment once their work is done.
As creator and founder of Sudoc, Dr. Collins states, “Given the ever-expanding number of toxic chemicals in common use today (over 300,000*) and the large number of chemicals that don’t degrade and persist for decades, I am delighted to see Sudoc introducing new products that can outperform toxic chemicals, but disappear when their work is done.”
Founder and CEO of Sudoc, Roger Berry, comments, “Carnegie Mellon University has supported an incredible body of research into a sustainable chemistry that could revolutionize how we think about a wide range of products and services. We can look forward to a broad and expanding array of opportunities, ranging from the creation of new cleaning products to the development of new environmental treatment solutions. The potential for this technology to transform the planet for the better is astonishing.”
The Associate Vice President and Head of the Center for Technology Transfer and Enterprise Creation at CMU, Robert Wooldridge, states, “Carnegie Mellon is proud to support Dr. Collins and his teams and is delighted to find a group of investors and entrepreneurs in Sudoc so well-suited to carrying out the commercialization efforts needed to bring this remarkable chemistry to market. This invention has incredible commercial promise, but, even more importantly, TAML catalysts can reverse the adverse impact of toxic chemicals on living beings.”
Sudoc was formed in 2020 with operations in Cambridge, MA, Charlottesville, VA, and Pittsburgh, PA and is developing a range of products that will, among other applications, treat mold, clean wastewater, and mineralize waste pharmaceuticals. By outperforming other technologies that currently perform these functions, Sudoc’s products will help to remove these harmful chemicals from our planet. To guarantee its commitment to the public good, Sudoc’s largest shareholder is a pair of trusts that will over time fund research into the problem of endocrine disrupting chemicals— those toxic chemicals that disrupt the hormone systems of living beings, reducing human fertility, inducing diseases, and adversely affecting behavior.
Carnegie Mellon University is a private, global research university that stands among the world’s most renowned educational institutions. CMU has 14,500+ students, 1,300+ faculty, and 109,900+ alumni from over 140 countries. CMU’s alliance with Sudoc aligns perfectly with its mission: “We don’t imagine the future, we create it.”
*Environ. Sci. Technol. 2020, 54, 2575−2584